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ABSTRACT
Transfer RNAs (tRNAs) function in translational machinery and further serves as a source of short
non-coding RNAs (ncRNAs). tRNA-derived ncRNAs show differential expression profiles and play
roles in many biological processes beyond translation. Molecular mechanisms that shape and regulate their expression profiles are largely unknown.
Here, we report the mechanism of biogenesis for
tRNA-derived Piwi-interacting RNAs (td-piRNAs) expressed in Bombyx BmN4 cells. In the cells, two cytoplasmic tRNA species, tRNAAspGUC and tRNAHisGUG ,
served as major sources for td-piRNAs, which were
derived from the 5 -part of the respective tRNAs.
cP-RNA-seq identified the two tRNAs as major substrates for the 5 -tRNA halves as well, suggesting
a previously uncharacterized link between 5 -tRNA
halves and td-piRNAs. An increase in levels of the 5 tRNA halves, induced by BmNSun2 knockdown, enhanced the td-piRNA expression levels without quantitative change in mature tRNAs, indicating that 5 tRNA halves, not mature tRNAs, are the direct precursors for td-piRNAs. For the generation of tRNAHisGUG derived piRNAs, BmThg1l-mediated nucleotide addition to −1 position of tRNAHisGUG was required, revealing an important function of BmThg1l in piRNA
biogenesis. Our study advances the understanding
of biogenesis mechanisms and the genesis of specific expression profiles for tRNA-derived ncRNAs.
INTRODUCTION
Transfer RNAs (tRNAs) are ∼70−90-nucleotides (nt) of
non-coding RNAs (ncRNAs) that are universally expressed
in all organisms and function as fundamental adapter components of translational machinery to translate mRNA
codons into amino acids of proteins (1,2). Besides their
role in translation, tRNAs further serve as substrates for
* To

shorter ncRNAs. In many organisms, specific ncRNAs are
produced from mature tRNAs or their precursor molecules
(pre-tRNAs) to serve as functional molecules, rather than
random degradation products (3–8). In general, tRNAderived ncRNAs are classified into two groups: tRNA
halves and tRNA-derived fragments (tRFs). tRNA halves
range either from the 5 -end to the anticodon-loop (5 -half)
or from the anticodon-loop to the 3 -end (3 -half) of a mature tRNA, and their production is triggered by stresses and
sex hormone signaling pathways (6,9,10). 5 -tRNA halves
have been shown to be functional molecules that regulate
translation, promote stress granule formation and cell proliferation, and are involved in neurodegenerative diseases
and aging (10–16). Generally shorter than tRNA halves,
tRFs originate from the 5 -part (5 -tRF), 3 -part (3 -tRF) or
wholly internal part (i-tRF) of mature tRNAs or other precursor sequences (3–8,17). They show differential but specific expression profiles in different cells and tissues and are
involved in many biological processes, such as cell proliferation, tumor suppression and priming of viral reverse transcriptase (3–8,17). Although tRF expressions might be able
to serve as indicators for biological states, it is still unknown
as to how the specific expression profiles of tRFs are shaped.
The functional significance of tRFs is particularly evident by their involvement in the pathway of small regulatory RNAs bound by Argonaute family proteins (7).
It has been shown that a variety of tRFs are selectively
and differentially loaded onto the Ago subclade of the
Argonaute family in human cells (17–24). These types of
Ago-loaded tRFs are further known to function as microRNAs (miRNAs) by repressing the expression of their
complementary target mRNAs. For example, Ago-bound
3 -tRFLysUUU (3 -tRF derived from tRNALysUUU ) silences
HIV-1 in MT4 T-cells (25), while Ago-bound 3 -tRFGlyGCC
modulates DNA damage response by targeting RPA1 in
human B cells (26). The presence of Ago-bound tRFs has
also been reported for many other organisms, such as the
mouse (27), Drosophila (28,29), Bombyx (30) and in plant
(31). However, despite the widespread presence and evident functional significance of Ago-bound tRFs as miR-
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NAs, their biogenesis mechanisms remain largely elusive.
Although both Dicer-dependent and independent biogenesis pathways have been suggested (18,19,21,22,26,28,32),
the molecular mechanisms underlying the selection of tRNAs for miRNA biogenesis and specific and differential
Ago-loading of each of the tRFs is unknown.
Piwi proteins, the other Argonaute subclade, are predominantly expressed in the germline and are associated with
∼26−31-nt Piwi-interacting RNAs (piRNAs) to regulate
transposons and other targets for maintaining genome integrity (33,34). Piwi proteins, like Ago proteins, have also
been observed interacting with tRFs in various organisms,
such as human (35), marmoset (36), Drosophila (37–39),
and Trypanosoma (40). The functional significance of Piwibound tRFs was shown in Tetrahymena where TWI12 was
tightly bound to tRFs, and played crucial roles in stimulating Xrn2 exonuclease for nuclear RNA processing (41,42).
However, as in the case of Ago-loaded tRFs, the biogenesis mechanisms producing Piwi-bound tRFs remain unknown. Only specific species of tRFs are selectively loaded
onto Piwi proteins as piRNAs. For example, 5 -tRFGluCUC
is predominantly loaded onto the Piwi protein in marmoset
testes (36), while 5 -tRFGluUUC and i-tRFGluUUC are abundant as Piwi-bound tRFs in Drosophila Kc167 cells (39).
The molecular mechanisms underlying the selection of tRNAs for piRNA biogenesis and specific Piwi-loading of different tRF species in different organisms are completely unknown.
To unravel the emerging complexities of tRF biology,
it is imperative to understand the tRF biogenesis mechanism that induces specific expression profiles of tRFs. Here
we report the characterization of the expression profile
and biogenesis mechanism of tRNA-derived piRNAs (tdpiRNAs) by utilizing BmN4 cells, a culturable germ cell
line derived from Bombyx mori ovary. BmN4 cells possess
fully functional primary and secondary piRNA biogenesis pathways, and express both Bombyx Piwi proteins, Siwi
and BmAgo3, as well as their bound piRNAs (43). Because of the scarcity of piRNA-expressing culturable germ
cell line, BmN4 cells have been used often to elucidate the
piRNA biogenesis mechanism and its required protein factors (44–48). Our analyses of Siwi- and BmAgo3-bound
piRNAs showed that 5 -tRFs of only specific tRNA species
are abundantly expressed as Piwi-bound td-piRNAs. Furthermore, unraveling expression profiles of 5 -tRNA halves
revealed a previously uncharacterized link between the expressed species of tRNA halves and td-piRNAs. Our additional experimental validations suggest a model in which 5 tRNA halves, not mature tRNAs, are the direct precursors
for td-piRNAs. These results explain why specific expression profiles of td-piRNAs are governed in the cells. Our
study advances the understanding of the biogenesis mechanisms for the Argonaute-interacting, tRNA-derived regulatory RNAs and provides the example of how specific tRF
expression profiles are shaped.

MATERIALS AND METHODS
BmN4 cell culture, RNA isolation, enzymatic treatment and
␤-elimination
BmN4 cells were cultured at 27◦ C in Insect-Xpress medium
(Lonza). RNA isolation, enzymatic treatment, and ␤elimination were performed as previously described (10,44).
In brief, total RNA was isolated using the TRIsure reagent
(Bioline). To investigate the 3 -terminal structures of 5 tRNA halves, total RNA was treated with calf intestinal
alkaline phosphatase (CIP; New England Biolabs) or T4
polynucleotide kinase (T4 PNK; New England Biolabs),
and then subjected to qRT-PCR detection of 5 -tRNA
halves and piRNAs (see below section). To investigate the
3 -terminal structures of 3 -tRNA halves, total RNA was
first subjected to deacylation treatment, followed by a ␤elimination reaction. For deacylation, total RNA was incubated in 20 mM Tris-HCl (pH 9.0) at 37◦ C for 40 min. For
␤-elimination, total RNA was first incubated with 10 mM
NaIO4 at 0◦ C for 40 min in the dark. 1 M rhamnose (1/10
volume) was then added to quench unreacted NaIO4 and
incubated at 0◦ C for 30 min. Subsequently, ␤-elimination
was performed by adding an equal volume of 2 M Lys-HCl
(pH 8.5) and incubating at 45◦ C for 90 min. The treated total RNA was then subjected to Northern blot detection of
3 -tRNA halves (see below section).
Quantification of 5 -tRNA halves and td-piRNAs by TaqMan
qRT-PCR
TaqMan qRT-PCR quantification of 5 -tRNA halves and
td-piRNAs was performed according to our previouslydescribed tRNA halves’ quantification method (10) with
modifications (Supplementary Figure S1). Total RNA was
at first incubated with 10 mM NaIO4 at 0◦ C for 40 min
in the dark to disrupt 3 -OH ends of RNAs; 5 -tRNA
halves and piRNAs survive the treatment because of the
presence of a 2 ,3 -cyclic phosphate (cP) and 2 -O-methyl
modification at the 3 -end, respectively. For quantification of 5 -tRNA halves (5 -halfAspGUC and 5 -halfHisGUG ),
total RNA was then treated with T4 PNK to dephosphorylate the 3 -end of 5 -tRNA halves. For quantification of td-piRNAs (td-piRAspGUC and td-piRHisGUG ),
the NaIO4 -treated RNA was subjected to the next step
without any pretreatment. For both cases, 100 ng of
the treated RNAs were subjected to a ligation reaction
(10-L reaction mixture) with 20 pmol of a 3 -RNA
adaptor (5 -P-GAACACUGCGUUUGCUGGCUUUG
AGAGUUCUACAGUCCGACGAUC-ddC-3 ) using T4
RNA Ligase (T4 Rnl; Fisher Scientific). Subsequently, 1 ng
of ligated RNA was subjected to TaqMan qRT-PCR (10L reaction mixture) using the One Step PrimeScript RTPCR Kit (Clontech), 400 nM of a TaqMan probe targeting
the boundary of the targeted RNA and 3 -RNA adaptor,
and 2 pmol each of specific forward and reverse primers.
With the StepOne Plus Real-time PCR machine (Life Technologies), the reaction mixture was incubated at 42◦ C for 5
min and then 95◦ C for 10 s, followed by 40 cycles of 95◦ C
for 5 s and 60◦ C for 34 s. The quantified RNA levels were
normalized to the levels of Bombyx 5S rRNA quantified by
qRT-PCR using a stem-loop reverse primer (see below sec-
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tion). The sequences of the primers and TaqMan probes are
shown in Supplementary Table S1.
Northern blot
Northern blot analysis was performed as described previously (44). Briefly, 5 g of total RNA were resolved by 12%
PAGE containing 7 M urea using the SE400 Electrophoresis
Unit (Hoefer) or sequencing system aluminum 2 (Thermo
Fisher Scientific), transferred to Hybond N+ membranes
(GE Healthcare), and hybridized to 5 -end-labeled antisense probes whose sequences are shown in Supplementary
Table S2.
cP-RNA-seq to selectively amplify and sequence 5 -tRNA
halves
cP-RNA-seq was performed as described previously
(10,49). Briefly, ∼30–40-nt RNAs were gel-purified from
BmN4 total RNA and treated with CIP. After phenolchloroform purification, the RNAs were oxidized by
incubation in 10 mM NaIO4 at 0◦ C for 40 min in the dark,
followed by ethanol precipitation. The RNAs were then
treated with T4 PNK. After phenol–chloroform purification, directional ligation of adapters, cDNA generation,
and PCR amplification were performed using the TruSeq
Small RNA Sample Prep kit (Illumina) according to the
manufacturer’s protocol. The amplified cDNAs were sequenced using Illumina hiSeq2000 system at the Functional
Genomics Core at the University of Pennsylvania.
Bioinformatics analyses
To identify td-piRNA sequences expressed in BmN4
cells, Bombyx tRNA reference sequences were extracted
by applying tRNA scan program (50) for Bombyx mori
genome (http://www.silkdb.org/silkdb/). Variant sequences
of Bombyx cytoplasmic (cyto) tRNAAspGUC , tRNAHisGUG ,
tRNAGluUUC , and tRNAGluCUC are shown in Supplementary Figure S2. The six piRNA libraries [1: SiwipiRNAs; 2: BmAgo3-piRNAs; 3: Siwi-piRNAs from Rluc(control) depleted cells; 4: Siwi-piRNAs from BmPapidepleted cells; 5: BmAgo3-piRNAs from Rluc-depleted
cells; 6: BmAgo3-piRNAs from BmPapi-depleted cells;
DDBJ #DRA002562], obtained from Siwi- or BmAgo3immunoprecipitates of BmN4 cells in our previous study
(44), were then mapped to the tRNA reference sequences
using SHRiMP2 (51), which allowed a 4% mismatch rate
(no insertions or deletions allowed), soft clipping, and nonunique mappings. In the subsequent analyses shown in Figure 1, we focused on the reads over 1 rpm.
To identify 5 -tRNA halves expressed in BmN4 cells, the
cP-RNA-seq-yielded library was analyzed. The library contains 54 054 137 raw reads and is publically available at
NCBI’s Sequence Read Archive (accession no. SRP107958).
Prior to mapping, we used the cutadapt tool (DOI: http:
//dx.doi.org/10.14806/ej.17.1.200) to remove the 3 -adapter
sequence (5 -TGGAATTCTCGGGTGCCAAGG-3 ). The
adapter-removed sequences (52 806 536 reads) were mapped
to Bombyx tRNA sequences as described above, resulting
in 59.3% mapped ratio (31 338 554 reads were mapped to

tRNAs). In the subsequent analyses shown in Figure 3, we
focused on the reads over 1 rpm and over 30 nt in length,
which in aggregate accounted for ∼99.2% of the mapped
reads.
RNAi knockdown of BmThg1l and BmNSun2 in BmN4 cells
From SilkBase (http://silkbase.ab.a.u-tokyo.ac.jp/cgi-bin/
index.cgi), we retrieved the BGIBMGA002973-TA and
BGIBMGA004408-TA GeneModel sequences as significant homologs to human THG1L (NP 060342.2) and
NSUN2 (NP 060225.4) using tblastn algorism; these genes
were named as BmThg1l and BmNSun2, respectively (Supplementary Figures S3 and S4). RNAi knockdowns of
BmThg1l and BmNSun2 in BmN4 cells was performed
as described previously (44) with minor modifications.
Briefly, to synthesize templates for the in vitro production
of dsRNA, BmN4 total RNA was extracted using RNeasy
mini kit (Qiagen), and reverse transcription was performed
with random hexamer primers. The resultant cDNAs were
used as templates for PCR with specific forward and reverse
primers shown in Supplementary Table S3. The amplified
DNAs containing T7 promoter sequence on both strands
were used as templates in a T7 in vitro transcription system (MEGAscript T7, Ambion), followed by purification
with MEGAclear (Ambion). The synthesized and purified
dsRNA (6 g) was transfected into 3 × 106 BmN4 cells using 4D-Nucleofector (Lonza). After culturing for 5 days, an
identical dsRNA transfection was performed again. After
culturing for another 2 days, to accelerate de novo synthesis
of piRNAs, 6 g of a pIZ-based plasmid encoding FLAGtagged Siwi or BmAgo3 (44) were transfected using 30 l
of Escort IV Transfection Reagent (Sigma) into BmThg1lor BmNsun2-depleted cells, respectively. After culturing for
another 2 days, the cells were harvested for the analyses of
piRNAs, tRNAs, tRNA halves and mRNAs. To confirm
the efficiency of the RNAi knockdowns, the expression levels of targeted mRNAs were analyzed by qRT-PCR using
2 × qPCR Master Mix (Bioland Scientific LLC) and the
primers shown in Supplementary Table S4. BmRp49 was
used as a control for normalization.
qRT-PCR using a stem-loop reverse primer
Two piRNAs (piR-1 and piR-2) and let-7 miRNA were
quantified by qRT-PCR using a stem–loop reverse primer
that is based on miRNA quantification by stem-loop qRTPCR (52). By using StepOne Plus Real-time PCR machine
(Life Technologies), the reaction mixture consisted of OneStep SYBR PrimeScriptª RT-PCR Kit II (Clontech) and
the primers shown in Supplementary Table S5 was incubated at 16◦ C for 15 min, 42◦ C for 15 min, and then 95◦ C
for 10 s, followed by 40 cycles of 95◦ C for 5 s and 60◦ C for
34 s. 5S rRNA was used as a control for normalization.
RESULTS
Cytoplasmic tRNAAspGUC and tRNAHisGUG are rich sources
of piRNAs in BmN4 cells
Our previous analyses, using BmN4 cells, detected the expression of piR-a, which is derived from the 5 -part of Bombyx cytoplasmic (cyto) tRNAAspGUC (10). The piR-a is a

Nucleic Acids Research, 2017, Vol. 45, No. 15 9111

Figure 1. Identification of td-piRNAs in BmN4 cells. (A) BmN4 Siwi- or BmAgo3-bound piRNAs were mapped against Bombyx mori tRNA sequences.
Among the tRNA-mapped piRNA reads, pie charts show the percentages of the reads derived from respective cyto tRNA species. (B) The 5 -terminal
position of Siwi- or BmAgo3-bound td-piRAspGUC or td-piRHisGUG in the respective mature tRNA. Nucleotide positions (np) are indicated according to
the nucleotide numbering system of tRNAs (2). (C) The regions from which td-piRAspGUC , starting from np 1, or td-piRHisGUG , starting from np –1, were
derived are shown in black in the cloverleaf secondary structure of Bombyx cyto tRNAAspGUC -V1 (Supplementary Figure S2) and tRNAHisGUG . NonpiRNA-derived regions are shown in gray. (D) Read-length distribution of the Siwi- or BmAgo3-bound total piRNAs, td-piRAspGUC , or td-piRHisGUG
identified in Rluc-depleted (control) or BmPapi-depleted BmN4 cells.
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5 -tRFAspGUC sharing an identical 5 -end with the mature
tRNA and corresponding to the nucleotide position (np) 1–
28 (np is according to the nucleotide numbering system of
tRNAs (2)). Because piR-a was among the most abundant
piRNA species detected in our previous piRNA sequencing (44), we hypothesized that tRNAs are rich sources of
piRNAs in BmN4 cells. To explore the td-piRNA species,
we mapped Siwi- or BmAgo3-bound piRNA sequences,
previously identified by Illumina sequencing of the RNAs
from Siwi- or BmAgo3-immunoprecipitates (44), to Bombyx tRNA sequences. Among the tRNA-mapped reads, we
focused on RNA species with >1 reads per million (rpm).
Among the total 52 species of Bombyx cyto tRNA isoacceptors, only a few cyto tRNA species were found to be major sources of Siwi- or BmAgo3-bound td-piRNAs (Figure
1A). The two species, cyto tRNAAspGUC and tRNAHisGUG ,
were particularly enriched as td-piRNA sources, comprising 86.9% or 97.1% of the total Siwi- or BmAgo3-bound
td-piRNAs, respectively. Most td-piRAspGUC were derived
from np 1–25∼29 of mature tRNAAspGUC (Figure 1B and
C). As mature tRNAHisGUG is known to contain one extra evolutionally-conserved 5 -terminal nucleotide at np –1
(2,53), td-piRHisGUG was derived mainly from np –1–23∼29
of mature tRNA (Figure 1B and C). Therefore, both tdpiRNAs belong to 5 -tRF with an identical 5 -terminal position to mature tRNAs and with variations at their 3 terminal positions. Cyto tRNAGluUUC and/or tRNAGluCUC
were also found to be a source (6.5%) for Siwi-bound tdpiRNAs (Figure 1A), and td-piRGluUUC/CUC belongs to
5 -tRF as well (Supplementary Figure S5A and B). Although only 1% of the Siwi- or BmAgo3-bound piRNAs
are annotated to Bombyx tRNAs (44), the enrichment of
td-piRNAs for only specific species make those among the
most abundant piRNAs; the most abundant td-piRNAs,
td-piRAspGUC (np 1–28) in Siwi-bound piRNAs and tdpiRHisGUG (np –1–25) in BmAgo3-bound piRNAs, rank
among the top 20 of all identified individual piRNA species.
Therefore, cyto tRNAAspGUC and tRNAHisGUG are very rich
sources of piRNAs expressed in BmN4 cells.
In BmN4 cells, overall lengths of Siwi-bound piRNAs are
longer than BmAgo3-bound piRNAs (44). This tendency is
retained for both td-piRAspGUC and td-piRHisGUG (Figure
1D), suggesting that the two td-piRNAs are produced from
a canonical piRNA biogenesis mechanism. To further address this point, we analyzed the two td-piRNAs in BmPapidepleted BmN4 cells. BmPapi is a piRNA biogenesis factor
that localizes at the outer membrane of mitochondria and
supports PNLDC1-catalyzed 3 -end maturation of piRNAs
(44,48). Due to its role in piRNA 3 -end maturation, BmPapi depletion globally causes a 3 -terminal extension of
piRNA lengths (44). As shown in Figure 1D, the lengths of
both td-piRAspGUC and td-piRHisGUG in BmPapi-depleted
cells were longer than those in control cells, suggesting that
the two td-piRNAs are bona-fide piRNAs produced via a
canonical piRNA biogenesis mechanism, including the 3 end maturation step catalyzed by PNLDC1 in support of
BmPapi.
Because both td-piRAspGUC and td-piRHisGUG species
share identical 5 -ends with mature tRNAs, these tdpiRNAs are likely to originate from mature tRNAs result-

ing from the RNase P-mediated removal of 5 -leader sequences. However, mature tRNAs in the cytoplasm usually
exist as aminoacylated forms that are tightly bound by an
elongation factor for translation. Questions remained regarding how these tRNAs, forming rigid structures with
interacting proteins, enter a piRNA biogenesis system
where they are loaded onto Piwi proteins before PNLDC1mediated processing, and why only specific tRNA species
(i.e. tRNAAspGUC and tRNAHisGUG ) are selected for piRNA
production.
tRNA halves are produced from mature aminoacylated
tRNAAspGUC and tRNAHisGUG in BmN4 cells
In BmN4 cells, our previous study revealed abundant accumulation of tRNA halves derived from cyto tRNAAspGUC
and tRNAHisGUG (10). Both the 5 - and 3 -halves of the tRNAs manifested clear signals in northern blots, but we failed
to detect signals for tRNA halves from other randomly chosen tRNAs (10). Because the specific expression of tRNA
halves from cyto tRNAAspGUC and tRNAHisGUG was reminiscent of the specific expression of td-piRNAs from the two
tRNAs, we next analyzed the expression profiles of tRNA
halves.
In human hormone-dependent cancer cells, angiogenin
(ANG), a member of the RNase A superfamily, cleaves the
anticodon-loop of mature tRNAs to generate: (i) 5 -halves
containing a 5 -terminal phosphate (5 -P) and a 3 -terminal
2 ,3 -cyclic phosphate (3 -cP) and (ii) 3 -halves containing
a 5 -terminal hydroxyl group (5 -OH) and a 3 -terminal
amino acid (3 -aa) (10). To analyze 3 -terminal structures of
the 5 -halves derived from tRNAAspGUC and tRNAHisGUG
(5 -halfAspGUC and 5 -halfHisGUG , respectively) expressed in
BmN4 cells, total RNA was treated with T4 polynucleotide
kinase (T4 PNK) or calf intestine phosphatase (CIP). T4
PNK removes both 3 -P and 3 -cP from RNAs, whereas
CIP removes only a 3 -P and cannot remove a 3 -cP. Subsequently, efficiency of the ligations between the 5 -halves
and a 3 -RNA adapter was examined by TaqMan qRT-PCR
with a TaqMan probe that targets the boundary of the 5 halves and the adapter. This was specifically for quantifying ligation products without cross-reaction from mature
tRNAs or unligated tRNA halves. As shown in Figure 2A,
the T4 PNK treatment, but not the CIP treatment, drastically increased the ligation efficiency of an RNA adapter to
5 -halves. No such increase was observed in control experiments for piRNAs which do not contain 3 -cP. These results
suggest that 5 -halves contain a 3 -terminal cP, as shown in
the 5 -halves expressed in human cancer cells.
To analyze the 3 -terminal structure of the 3 -half, BmN4
total RNA was subjected to deacylation treatment to remove amino acids from aminoacylated tRNAs. This was
followed by sodium periodate oxidation and ␤-elimination,
which reacts with the 3 -OH end to remove the 3 -terminal
nucleotide (10). As shown in Figure 2B, ␤-eliminated 3 halfAspGUC and 3 -halfHisGUG , as well as corresponding mature tRNAs, migrated faster than unreacted RNAs only
after the RNAs were subjected to the deacylation treatment. In other words, without the deacylation treatment,
␤-elimination was unable to react with the 3 end of the 3 halves and the mature tRNAs because of the presence of an
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Figure 2. Terminal structure analyses of tRNA halves expressed in BmN4
cells. (A) The 3 -terminal structures of 5 -tRNA halves and td-piRNAs
derived from tRNAAspGUC and tRNAHisGUG were analyzed enzymatically. BmN4 total RNA was treated with CIP or T4 PNK (PNK). NT
designates non-treated samples used as negative controls. The treated total RNA was subjected to 3 -adapter ligation by T4 Rnl, and the ligation
efficiency was estimated by quantifying adapter-ligated target RNAs (5 tRNA halves or piRNAs) using TaqMan qRT-PCR. Ligated products in
NT samples were set as 1, and relative amounts are indicated. Averages of
three independent experiments with SD values are shown. (B) To analyze
the 3 -terminal structure of 3 -tRNA halves, BmN4 total RNA was subjected to deacylation treatment and sodium periodate oxidation, followed
by ␤-elimination. The mature tRNAAspGUC , 3 -halfAspGUC , tRNAHisGUG ,
3 -halfHisGUG , and let-7 miRNA (control) in the treated total RNA were
analyzed by Northern blots.

amino acid. Control let-7 miRNA migrated faster after ␤elimination, both with and without deacylation treatment,
because let-7 does not have an amino acid. These results
suggest that the 3 -halves are fully aminoacylated as shown
in the 3 -halves expressed in human cancer cells (10), and
therefore that the production of 5 - and 3 -halves occur via
an anticodon-loop cleavage of mature aminoacylated tRNAs in BmN4 cells.
5 -tRNA halves in BmN4 cells are derived from only specific
tRNA species including tRNAAspGUC and tRNAHisGUG
The 3 -terminal cP or amino acid of tRNA halves would inhibit the adapter ligation step included in standard RNAseq methods, and therefore, the expression of tRNA halves
cannot be captured by analyzing standard RNA-seq data.
Instead, we utilized ‘cP-RNA-seq’ to identify expression
profiles of 5 -halves expressed in BmN4 cells because it
is able to selectively amplify and sequence RNAs containing a 3 -cP (10,49). Because selective amplification of
cP-containing RNAs in this method is dependent on the
periodate-mediated cleavage of other RNAs with a 3 -OH
end, the 3 -terminal ribose 2 -O-methylation of piRNAs
(54–57) was expected to make piRNAs amplifiable by cPRNA-seq despite the absence of a 3 -cP (49). Indeed, as
shown in Figure 3A, piRNAs were amplified by the proce-

dures even without CIP and T4 PNK treatments as ∼145bp cDNA bands (considering adapters’ lengths, inserted
RNAs were estimated to be ∼27 nt). However, the full cPRNA-seq procedures amplified ∼153-bp cDNA bands (inserted RNAs: ∼35 nt) that were much more abundant than
piRNA bands in the same lane (Figure 3A). The dependency of the bands on T4 PNK treatment suggests that,
as expected, the bands were derived from cP-containing 5 tRNA halves.
Illumina sequencing of the ∼153-bp cDNA bands
yielded ∼53 million reads after the quality check and
adapter trimming, of which ∼31 million reads (∼59%)
were actually mapped against Bombyx tRNA sequences.
The tRNA-mapped reads were mostly 33 or 34 nt in
length (Figure 3B), and derived from specific species of
tRNAs. When we focused the tRNA-mapped reads to
greater than 1 rpm with over 31-nt length that in aggregate accounted for 99.2% of the reads, only four cyto
tRNA species (tRNAAspGUC , tRNALysCUU , tRNAHisGUG
and tRNALysUUU ) were identified to be a source of the
reads with >1% of the tRNA-mapped reads, and another four cyto tRNA species (tRNAGluUUC , tRNAGlyGCC ,
tRNAGluCUC and tRNAGlnCUG ) corresponded to the reads
with 0.2−1% of the tRNA-mapped reads (Figure 3C).
Reads derived from tRNAAspGUC were particularly enriched, comprising 85.1% of the total tRNA-mapped reads.
Of the reads mapped to the four tRNAs, almost all sequences were unanimously derived from 5 -halves ranging
from the 5 -end [np 1 (or np –1 for tRNAHisGUG )] to np
32–35 (Figure 3D). The abundant presence of 5 -halfAspGUC
and 5 -halfHisGUG was consistent with the results from the
Northern blots in our previous study (10). Further northern blots confirmed the accumulation of 5 -halfLysCUU and
5 -halfGluUUC/CUC , as identified by cP-RNA-seq, but not of
unidentified 5 -halves derived from randomly-chosen tRNAs, tRNAGlyUUC , tRNASerCGA and tRNATyrGUA (Supplementary Figures S5 and S6), suggesting credibility of the
cP-RNA-seq results. Although we failed to find a homolog
of ANG in the Bombyx genome and the enzyme that cleaves
tRNAs in BmN4 cells is unidentified, major cleavage sites
within the anticodon-loop were located between cytidine
and uridine or guanosine and uridine (Figure 3E). This is
similar to the ANG-cleavage patterns for the production of
tRNA halves in human cancer cells (10).
BmThg1l-mediated uridine addition at –1 np of tRNAHisGUG
is required for the expression of td-piRHisGUG
Among all species of tRNAs, tRNAHisGUG is unique in
that it contains an additional 5 -terminal nucleotide at np
−1. Although the presence of guanosine at np −1 (G−1 )
has been widely known to be conserved across phyla (2),
our recent study revealed the existence of other three −1
nucleotides (U−1 >> A−1, C−1 ) in tRNAHisGUG , in addition to G−1 , and its 5 -half expressed in human BT-474
breast cancer cells (53). As observed in BT-474 cells, cPRNA-seq data showed wide variations of 5 -terminal nucleotides from 5 -halfHisGUG in BmN4 cells. In addition to
5 -halfHisGUG lacking a −1 nucleotide (G1 ) or containing
G−1 , 5 -halfHisGUG containing U−1 and A−1 also were substantially expressed (16.6% and 10.7%, respectively) (Figure
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Figure 3. Identification of 5 -tRNA halves in BmN4 cells by the cP-RNA-seq method. (A) BmN4 ∼30–40-nt RNAs were gel-purified and applied to cPRNA-seq method. The full-procedure mainly amplified ∼153-bp cDNA products (5 -adapter, 55 bp; 3 -adapter, 63 bp; and therefore inserted sequences,
∼35 bp) as indicated by an arrowhead, while the procedure without CIP and T4 PNK treatments amplified ∼146-bp cDNA products (inserted sequences,
∼28 bp) as indicated by black circles. (B) Read-length distribution of the tRNA-mapped reads. (C) Pie chart showing the percentages of reads derived
from respective cyto tRNA species. 5 -terminal nucleotides of each tRNA are shown in parenthesis. (D) Pie charts showing the mature tRNA regions from
which the sequenced 5 -tRNA halves were derived. (E) The anticodon-loop cleavage sites were predicted based on the 3 -terminal positions of 5 -tRNA
halves, and the percentages of the sites are shown.

4A). In contrast, the majority of both Siwi- and BmAgo3bound td-piRHisGUG contained U−1 (Figure 4B), suggesting
that tRNAHisGUG containing a 5 -terminal U−1 is selectively
used to produce td-piRHisGUG . The observation is consistent with the major presence of a 5 -terminal uridine in piRNAs and the selective loading of 5 -U-containing RNAs on
Piwi proteins as piRNA precursors in BmN4 cells (47).
As 5 -halfHisGUG originates from mature tRNAHisGUG , a
U−1 nucleotide should be present in mature tRNAHisGUG .
The Bombyx mori genome contains 14 tRNAHisGUG genes
that encode identical mature tRNAHisGUG sequences. Because all 14 genes have adenosine at their −1 positions
on the genome, the U−1 nucleotide should be added
post-transcriptionally. tRNAHis guanylyltransferase (Thg1)
has been shown to post-transcriptionally add G−1 to
tRNAHisGUG (58). We retrieved sequences of the BmThg1l
gene, a Bombyx homolog of the human THG1L, which
is localized on Bm scaf13 of chromosome 4 (Supplementary Figure S3). Because Thg1 or Thg1-like protein from
Bacillus, archaea, and yeast can attach not only G−1 , but
also U−1 , to the tRNA in vitro (59,60), we hypothesized
that the BmThg1l protein is involved in the U−1 addition

to tRNAHisGUG , which is required for the production of
td-piRHisGUG . To examine this, we performed an RNAi
knockdown of BmThg1l expression, which was effective
for decreasing BmThg1l mRNA levels to ∼12% compared
with the control knockdown (Figure 4C). The BmThg1l
knockdown did not change the staining patterns of total
RNA and the total piRNA fraction (Figure 4D). Strikingly, Northern blot using a large-size gel with a single nucleotide resolution revealed a lack of −1 nucleotides in mature tRNAHisGUG upon BmThg1l depletion (Figure 4E).
Moreover, the BmThg1l knockdown caused a removal of
the −1 nucleotide of 5 -halfHisGUG (Figure 4F). These results suggest that BmThg1l is the enzyme that adds the
−1 nucleotide to mature tRNAHisGUG in BmN4 cells, and
that the anticodon cleavage of the tRNA occurs after the
−1 nucleotide addition, so that the −1 nucleotide property
can be inherited by its 5 -half. TaqMan qRT-PCR quantification revealed the specific reduction of td-piRHisGUG
upon BmThg11 depletion. All other examined piRNAs
showed no quantitative changes (Figure 4G), which is consistent with the unchanged levels of total piRNAs shown
in Figure 4D. The specific requirement of BmThg1l for
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Figure 4. Analyses of tRNAHisGUG and td-piRHisGUG in BmThg1l-depleted BmN4 cells. (A) Pie chart showing the 5 -terminal variations of BmN4 5 halfHisGUG identified by cP-RNA-seq. (B) Pie charts showing the 5 -terminal variations of BmN4 td-piRHisGUG bound to Siwi and BmAgo3. (C) BmThg1l
mRNA from BmN4 cells treated with dsRNAs targeting Renilla luciferase (Rluc, negative control) or BmThg1l was quantified by qRT-PCR. Each data set
represents the average of three independent experiments with bars showing the SD. (D) Total RNA from Rluc- or BmThg1l-depleted cells was subjected to
denaturing PAGE and stained by SYBR Gold. Long exposure enabled clear observation of the piRNA bands. (E, F) Total RNA from Rluc- or BmThg1ldepleted cells was subjected to Northern blot targeting the 5 -part of tRNAHisGUG using a large-size gel with 1 nt resolution for mature tRNA (E) or a
standard-size gel for its 5 -half (F). Because the 5 -part of the tRNA is targeted, both mature tRNAHisGUG and 5 -halfHisGUG were detected. td-piRHisGUG
was not detected due to a lack of sensitivity. For both mature tRNA and 5 -half, a band with slightly smaller size appeared upon BmThg1l-depletion,
suggesting the role of BmThg1l in the –1 nucleotide addition to tRNAHisGUG . Bands shown with an asterisk might be non-specific as they seemed unaffected
by the BmThg1l depletion. (G) The indicated piRNAs and let-7 miRNA in the Rluc- or BmThg1l-depleted cells were quantified by TaqMan qRT-PCR
(Supplementary Figure S1) or qRT-PCR using a stem-loop primer. The amounts in Rluc-depleted cells were set as 1, and relative amounts are indicated.
Averages of three independent experiments with SD values are shown.
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td-piRHisGUG expression suggests that BmThg1l adds not
only G−1 but also U−1 to tRNAHisGUG , which produces 5 U−1 -containing precursors for specific loading onto Piwi
proteins to generate td-piRHisGUG . These results revealed
the important function of BmThg11 in the formation of
tRNAHisGUG −1 nucleotide and in the production of tdpiRNA.
The expression of 5 -halves is linked to the expression of tdpiRNAs
Both tRNA species identified as major sources for tdpiRNAs, tRNAAspGUC and tRNAHisGUG (Figure 1), also
have been identified as major sources for 5 -tRNA halves
(Figure 3). tRNAGluUUC and/or tRNAGluCUC have also
been detected as a source for both td-piRNAs and 5 tRNA halves. This link has prompted us to hypothesize
that 5 -halves, not mature tRNAs, could be direct intermediate precursors for the production of td-piRNAs. A
high proportion of piRNAs contain a uridine at their 5 end, and the presence of 5 -terminal uridine is a prerequisite for piRNA precursors to be loaded onto Piwi proteins
in BmN4 cells (47). If mature tRNAs are direct substrates
in piRNA biogenesis, the specific utilization of the limited
tRNA species for piRNA production would need additional
unknown mechanisms, because eight out of total 52 tRNA
isoacceptors contain a 5 -terminal uridine. Alternatively,
our hypothesis could explain the reason why tRNAAspGUC ,
tRNAHisGUG and tRNAGluUUC/CUC produce piRNAs in
BmN4 cells, because the 5 -halfAspGUC , 5 -halfHisGUG , 5 halfGluUUC and 5 -halfGluCUC are the only identified 5 -half
species containing a 5 -terminal uridine (Figures 3C and
4A). Among the eight major 5 -half species expressed in
BmN4 cells, the other four species contain a 5 -terminal
guanosine that would prevent them from being loaded onto
Piwi proteins and thereby make them inappropriate piRNA
precursors.
To examine the involvement of 5 -halves in the biogenesis of td-piRNAs, we focused on NSun2, an RNA
methyltransferase that methylates tRNAs to generate a 5methylcytosine (m5 C) modification (61,62). The NSun2produced m5 C modification protects the modified tRNAs
from the anticodon cleavage and, therefore, prevents the
generation of tRNA halves (14,63). In cells lacking NSun2
activity, the loss of the m5 C modification made tRNAs
more susceptible to anticodon cleavage and caused an accumulation of tRNA halves (14). These studies have designated NSun2 as a regulator factor for tRNA half expression. From the Bombyx genome, we retrieved sequences
of the BmNSun2 gene, a Bombyx homolog of the human
NSUN2, which is localized on Bm scaf37 of chromosome
20 (Supplementary Figure S4). RNAi knockdown of BmNSun2, which was effective in decreasing BmNSun2 mRNA
levels to ∼20% compared with the control reaction (Figure
5A), did not alter the expression patterns of total RNAs
(Figure 5B) or control 5S rRNA (Figure 5C). In contrast,
as expected, Northern blots showed the increased levels of
both 5 -halfAspGUC and 5 -halfHisGUG upon BmNSun2 depletion, whereas the levels of corresponding mature tRNAs
showed no alteration (Figure 5D). Strikingly, along with the
increase in the 5 -halves, expression levels of td-piRAspGUC

also increased upon BmNSun2 depletion (Figure 5D), although total piRNA abundance seemed not to have been altered (Figure 5B). Similarly, BmNSun2 depletion increased
the levels of 5 -halfGluUUC and td-piR GluUUC/CUC (Supplementary Figure S5C).
Because our northern blot lacked the sensitivity to detect td-piRHisGUG as a clear band (Figure 5D), we established a more sensitive TaqMan qRT-PCR method (Supplementary Figure S1) that can selectively and specifically
quantify 5 -halfAspGUC (np 1–34), td-piRAspGUC (np 1–28),
5 -halfHisGUG (np –1–34) and td-piRHisGUG (np –1–26). Total RNA was first subjected to sodium periodate oxidation to disrupt the 3 -OH ends of RNAs. For quantification of the piRNAs, subsequently, a 3 -adapter was ligated
to the 3 -ends of the piRNAs, and quantification of the ligation products was then achieved by TaqMan qRT-PCR. For
quantification of the 5 -halves, the periodate-treated RNA
was further treated with T4 PNK to remove a 3 -cP, and
then followed by a 3 -adapter ligation and TaqMan qRTPCR quantification. These methods revealed that the expression levels of both 5 -halfAspGUC and 5 -halfHisGUG as
well as their corresponding td-piRNAs, td-piRAspGUC and
td-piRHisGUG , were all enhanced upon BmNSun2 knockdown (Figure 5E). Taken together, these data suggest that,
in BmNSun2-deleted cells, an increase in the expression
levels of 5 -halves enhanced the expression levels of corresponding td-piRNAs without quantitative change in mature tRNAs, indicating that the 5 -halves, not the mature
tRNAs, are the direct precursors for td-piRNAs.
DISCUSSION
The number of reports characterizing the expression and
function of tRNA-derived ncRNAs has been growing,
which enforces the conceptual consensus that tRNAs are
utilized to produce functional ncRNAs. A wide variety of
specific tRFs are differentially expressed in different cells,
tissues, and organisms; however, the molecular mechanisms
governing the specific expression patterns of tRFs have not
been clarified yet. Although the functional significance of
tRFs has been increasingly apparent, the lack of information on their biogenesis mechanism limits our understanding of the necessity and inevitability of specific tRF expression profiles, as well as the reasons why cells utilize tRNAs
for ncRNA production.
Here we report the biogenesis mechanism for td-piRNAs
in Bombyx BmN4 cells, which could explain why only specific tRF species are expressed as piRNAs in the cells. In
the current model for canonical piRNA biogenesis pathways, single-stranded RNAs are transcribed from defined
genomic regions called piRNA clusters (37,64), and are
likely fragmented into shorter precursor piRNAs by the involvement of Zucchini endonuclease and other unknown
proteins (65–67). In BmN4 cells, precursor RNAs containing a 5 -terminal uridine are then selectively loaded
onto Piwi proteins, followed by a PNLDC1-catalyzed 3 - to
5 -exonucleolytic trimming, that is supported by BmPapi,
for the 3 -end formation of mature piRNAs (44,47,48).
Our analyses on Siwi- and BmAgo3-bound piRNAs identified the 5 -tRFs derived from cyto tRNAAspGUC and
tRNAHisGUG as major species of td-piRNAs (Figure 1).
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Figure 5. Analyses of 5 -tRNA halves and td-piRNAs in BmNSun2-depleted BmN4 cells. (A) BmNSun2 mRNA from BmN4 cells treated with dsRNAs
targeting Rluc (negative control) or BmNSun2 was quantified by qRT-PCR. Each data set represents the average of three independent experiments with
bars showing the SD. (B) Total RNA from Rluc- or BmNSun2-depleted cells was subjected to denaturing PAGE and stained by SYBR Gold. Long
exposure enabled clear observation of the piRNA bands. (C) Total RNA from Rluc- or BmNSun2-depleted cells was subjected to northern blot targeting
the Bombyx 5S rRNA. (D) Total RNA from Rluc- or BmNSun2-depleted cells was subjected to Northern blot targeting the 5 -part of mature tRNAAspGUC
and tRNAHisGUG . Because the 5 -part of the tRNA was targeted, 5 -half and td-piRNA, as well as mature tRNA, were all detected. We failed to detect
td-piRHisGUG due to a lack of sensitivity. The northern blot bands were quantified and shown as relative abundance in the right graph. Abundances in
Rluc-depleted cells were set as 1, and the averages of three independent experiments with bars showing the SD are shown. (E) The 5 -halves and td-piRNAs
in Rluc- or BmNSun2-depleted cells were quantified by TaqMan qRT-PCR. The amounts in Rluc-depleted cells were set as 1, and relative amounts are
indicated. Averages of three independent experiments with SD values are shown.

Our cP-RNA-seq identified tRNAAspGUC and tRNAHisGUG
as major sources for 5 -tRNA halves as well (Figure 3).
tRNAGluUUC and/or tRNAGluCUC were also detected as
substrates for both td-piRNAs and 5 -tRNA halves. We assumed the common appearance of these tRNAs as substrate for both td-piRNAs and 5 -tRNA halves was not
just a coincidence but fact suggesting a direct link between
the expression of td-piRNAs and 5 -tRNA halves. Indeed,
the increase of 5 -tRNA halves upon the knockdown of
BmNSun2 clearly enhanced td-piRNA expression (Figure
5). These data, together with unchanged levels of mature

tRNAs in BmNSun2-depleted cells, allow us to propose
a biogenesis mechanism for td-piRNAs in which 5 -tRNA
halves, rather than mature tRNAs, are the direct precursors
for td-piRNAs (Figure 6). In our model, mature tRNAs are
first cleaved at the anticodon-loop to produce tRNA halves.
Among the generated 5 -tRNA halves, only those containing a 5 -terminal uridine are loaded onto Piwi proteins to be
processed into td-piRNAs. Consequently, our model could
provide an explanation for the expression of only a few specific td-piRNA species.
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Figure 6. A proposed model of the biogenesis of td-piRNAs in BmN4 cells.

The molecular mechanism underlying the anticodonloop cleavage of only specific tRNA species in BmN4
cells remains unknown. In mammalian cells, ANG cleaves
the anticodon-loops of mature tRNAs to produce tRNA
halves, which is triggered by stresses and sex hormone signaling pathways (9,10,68). Although we could not find the
Bombyx homolog of human ANG, the presence of a 3 cP in 5 -tRNA halves (Figure 2) and major anticodonloop cleavage sites between cytidine and uridine or guanosine and uridine (Figure 3) resembles the characteristics of
ANG-generated 5 -tRNA halves in human cancer cells (10).
Therefore, an endonuclease similar to ANG could be involved in the production of tRNA halves in BmN4 cells.
In contrast to previous reports describing the 5 -terminal
G−1 as a major presence in tRNAHisGUG , the identified 5 terminal variations of 5 -halfHisGUG revealed the substantial
presence of the U−1 residue (Figure 4), which is consistent
with our recent study on 5 -halfHisGUG in human cancer cells
(53). The major presence of the U−1 residue in td-piRHisGUG
(Figure 4) should be attributable to their selective loading onto Piwi proteins. The expression of td-piRHisGUG is
clearly dependent on BmThg1l (Figure 4), suggesting that
BmThg1l contributes to the activity of adding U−1 , as well
as G−1 , to tRNAHisGUG , and that the BmThg1l protein is a
significant regulator for the expression of tRFs derived from
tRNAHisGUG .
Why are piRNAs not produced from mature tRNAs, but
from tRNA halves? Since an amino acid was attached to the
3 -end of the 3 -tRNA half (Figure 2), tRNA halves should
be produced by an anticodon-loop cleavage of mature
aminoacylated tRNAs. Aminoacylated tRNAs are tightly
bound by an elongation factor for translation. Therefore,
their structure might be too rigid for piRNA biogenesis factors and/or Piwi proteins to access for piRNA production.
The anticodon-loop could be among the most readily accessible regions for enzymes, which might be the reason that
mature tRNAs are first cleaved at anticodon-loop, and then
resultant tRNA halves, released from an elongation factor,
become direct precursors for piRNAs. If this is the case,
it might be possible that tRNA halves could also be direct precursors for many other tRFs, such as tRNA-derived
miRNAs bound by Ago proteins. Because the expression of
tRNA halves is variable in different cells and tissues, and

is further regulated by tRNA modification states, various
stressors, and hormones (9,10,14), the uniquely regulated
biogenesis mechanism of tRNA halves may consequently
provide the opportunity for cells to generate specific classes
of tRNA-derived small regulatory RNAs whose species and
abundance then also would be uniquely controlled. It will
be intriguing to examine further the role of tRNA halves
as direct precursors in the production of various shorter
tRFs. Such attempts will advance our knowledge on the significance and functional meaning of differential expression
profiles of tRNA-derived ncRNAs.
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